Rise of Sexually Transmitted Shigella and Antibiotic-Resistant Diarrhea

Approximately 450,000 people contract shigellose annually in the United States, facing an intestinal infection that causes colon inflammation, bloody diarrhea, and severe abdominal cramps, slate.fr reported. While the highly contagious Shigella bacteria historically spread through contaminated food, water, travel, or daycare centers, data indicates the pathogen has increasingly transformed into a sexually transmitted infection since the turn of the century.

Transmission Shifts Within Communities

According to slate.fr, the infection has become endemic within certain gay and bisexual communities, with sexual contact serving as a primary vector of transmission. The risk is compounded by the overuse of antibiotics to treat other sexually transmitted infections like gonorrhea, which has accelerated bacterial resistance across multiple drug classes.

Surge in Drug-Resistant Strains

In 2011, surveillance detected zero resistant samples. By 2023, data tracked by the Centers for Disease Control and Prevention showed that 8.5 percent of bacteria samples resisted the five main frontline antibiotics.

International Public Health Alarm

Dr. Gérald Kierzek, emergency physician and medical director at Doctissimo, warned that the pathogen is turning into a genuine public health threat. Doctissimo.fr reported that cases of ultra-resistant strains, known as XDR Shigella, jumped from a single recorded case throughout all of 2022 to a frequency of one case every month in the United States.

Parallel Findings Across the Atlantic

Geneticist Kate Baker of the University of Cambridge identified a parallel surge across the English Channel, as detailed in a study published in July in The Lancet Infectious Diseases. Baker stated that the illness has shifted from a readily treatable condition into a near-incurable one over the past decade, with the UK Health Security Agency reporting a rising tally of resistant infections by March.

Treatment Limits and Prevention Guidance

Doctissimo.fr outlined that standard treatment depends heavily on symptom severity and drug resistance profiles. Mild cases in healthy individuals typically resolve on their own within five to seven days through rest and rehydration. Conversely, severe cases or vulnerable populations require medical intervention, though the FDA has approved no oral antibiotic treatments for these resistant strains, occasionally necessitating intravenous options like meropenem under medical supervision.

Doctissimo.fr cautioned patients against using common over-the-counter anti-diarrheal medications such as Imodium or Lomotil, noting that such drugs can worsen the infection and prolong the illness. Public health guidance advises individuals to use condoms during oral and anal intercourse, wash hands before and after sexual contact, and abstain from sex for at least two weeks after any diarrhea symptoms completely clear.

Researchers track the continued spread of these overlapping variants as they evade standard pharmacological defenses. The UK Health Security Agency monitors resistant strain distributions while international teams assess clinical management strategies for patients requiring specialized intravenous therapies.